Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2011

May 19, 2011

30870_dirs_2011-05-19_c1d00926-f25a-4274-8890-8390a3231543.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2011-05-18

Reporting Person: DOW STEPHEN M (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-05-18 Common Stock $1.44 A 20000 Acquired 2021-05-18 Common Stock (20000) Direct

Footnotes

F1: Stock Options vest and are exercisable monthly over a period of twelve months and are fully vested on May 18, 2012.